| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/19/2000 | EP1019412A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht 1d? receptor antagonists |
| 07/19/2000 | EP1019410A1 Spiro-piperidine derivatives and their use as tachykinin antagonists |
| 07/19/2000 | EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 07/19/2000 | EP1019408A1 1,2,3,4-TETRAHYDRO-BENZOFURO 3,2-c]PYRIDINE DERIVATIVES-- |
| 07/19/2000 | EP1019406A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 07/19/2000 | EP1019405A1 Beta-methylcarbapenem derivatives, process for the preparation thereof and pharmaceutical composition comprising same |
| 07/19/2000 | EP1019404A1 Purine acyclonucleosides as antiviral agents |
| 07/19/2000 | EP1019402A1 Polymorphic forms of a growth hormone secretagogue |
| 07/19/2000 | EP1019400A1 Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| 07/19/2000 | EP1019399A1 Aryl thiophene derivatives as pde iv inhibitors |
| 07/19/2000 | EP1019398A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 07/19/2000 | EP1019397A1 A process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives |
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019395A1 Farnesyl transferase inhibiting 2-quinolone derivatives |
| 07/19/2000 | EP1019394A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS |
| 07/19/2000 | EP1019392A1 Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/19/2000 | EP1019391A1 Inhibitors of prenyl-protein transferase |
| 07/19/2000 | EP1019389A2 Epothilone derivatives |
| 07/19/2000 | EP1019387A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 07/19/2000 | EP1019386A1 Reverse hydroxamate derivatives as metalloprotease inhibitors |
| 07/19/2000 | EP1019385A1 Aminoaryl oxazolidinone n-oxides |
| 07/19/2000 | EP1019384A1 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
| 07/19/2000 | EP1019382A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 07/19/2000 | EP1019380A2 Tricyclic 3-oxo-propanenitrile compounds |
| 07/19/2000 | EP1019378A1 Hypoglycemic and hypolipidemic compounds |
| 07/19/2000 | EP1019377A1 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 (nk-3)- and neurokinin 2 (nk-2) receptor antagonists. |
| 07/19/2000 | EP1019376A1 Pyridone derivatives, their preparation and their use as synthesis intermediates |
| 07/19/2000 | EP1019374A1 Polymorphs of donepezil hydrochloride and process for production |
| 07/19/2000 | EP1019373A1 Novel human nk 3? receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 07/19/2000 | EP1019372A1 Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 07/19/2000 | EP1019370A1 Ace-inhibitor nitric salts |
| 07/19/2000 | EP1019369A1 Thio derivatives as naaladase inhibitors |
| 07/19/2000 | EP1019367A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use |
| 07/19/2000 | EP1019364A2 Inhibitors of protein tyrosine phosphatase |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019358A1 Novel compounds, their use and preparation |
| 07/19/2000 | EP1019096A2 Bioresorbable compositions for implantable prostheses |
| 07/19/2000 | EP1019090A1 Polymeric derivatives of camptothecins |
| 07/19/2000 | EP1019088A1 Composition for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 07/19/2000 | EP1019087A1 Ganglioside immunostimulating complexes and uses thereof |
| 07/19/2000 | EP1019083A1 Methods and compositions for the selective modification of nucleic acids |
| 07/19/2000 | EP1019079A1 Modulation of nitric oxide production |
| 07/19/2000 | EP1019076A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019072A1 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 07/19/2000 | EP1019069A2 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease |
| 07/19/2000 | EP1019067A1 Methods of using emu oil and active fractions thereof as an insect repellent |
| 07/19/2000 | EP1019066A1 Methods and compositions for preventing and treating heartburn |
| 07/19/2000 | EP1019065A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 07/19/2000 | EP1019063A1 Modulation of immune responses |
| 07/19/2000 | EP1019062A1 Osteoblast-specific mitogens and drugs containing such compounds |
| 07/19/2000 | EP1019061A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/19/2000 | EP1019060A1 Androgen synthesis inhibitors |
| 07/19/2000 | EP1019059A1 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION |
| 07/19/2000 | EP1019058A1 Pharmaceutical suspension comprising nevirapine hemihydrate |
| 07/19/2000 | EP1019057A1 A method of preventing or treating estrogen-dependent diseases and disorders |
| 07/19/2000 | EP1019056A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| 07/19/2000 | EP1019055A1 Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 07/19/2000 | EP1019054A1 Treatment of skin disorders |
| 07/19/2000 | EP1019053A1 Amorphous paroxetine composition |
| 07/19/2000 | EP1019052A1 Alpha 1a adrenergic receptor antagonists |
| 07/19/2000 | EP1019051A1 Peripherally acting anti-pruritic opiates |
| 07/19/2000 | EP1019050A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 07/19/2000 | EP1019049A1 Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (niddm) using specific retinoid compounds |
| 07/19/2000 | EP1019048A1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 07/19/2000 | EP1019047A1 Antithrombotic agents |
| 07/19/2000 | EP1019046A1 Protease inhibitors |
| 07/19/2000 | EP1019045A1 Antithrombotic agents |
| 07/19/2000 | EP1019044A1 Composition and methods for treating alzheimer's disease and other amyloidoses |
| 07/19/2000 | EP1019043A1 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same |
| 07/19/2000 | EP1019042A1 Anti-first-pass effect compounds |
| 07/19/2000 | EP1019041A1 Method of improving disturbed behavior and elevating mood in humans |
| 07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
| 07/19/2000 | EP1019039A1 Compressed nitroglycerin tablet and its method of manufacture |
| 07/19/2000 | EP1019038A1 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome |
| 07/19/2000 | EP1019037A1 Medicament containing delta-aminolevulinic acid |
| 07/19/2000 | EP1019036A1 Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 07/19/2000 | EP1019035A1 Il-8 receptor antagonists |
| 07/19/2000 | EP1019034A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/19/2000 | EP1019033A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | EP1019026A2 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 07/19/2000 | EP1019019A1 Buccal, polar and non-polar spray or capsule |
| 07/19/2000 | EP1019016A1 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex |
| 07/19/2000 | EP1018965A1 Method of treating the syndrome of coronary heart disease risk factors in humans |
| 07/19/2000 | EP1018896A1 Nutritional composition for the treatment of pressure ulcers |
| 07/19/2000 | EP1018880A1 2-methyl-thieno-benzodiazepine formulation |
| 07/19/2000 | EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 07/19/2000 | EP1018878A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
| 07/19/2000 | EP1018877A1 Low molecular weight cell, bone marrow and immune stimulants |
| 07/19/2000 | EP0902781A4 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
| 07/19/2000 | EP0863766B1 Methods for treating injury or degeneration of photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/19/2000 | EP0821682B1 Benzimidazole compounds and their use as modulators of the gaba-a receptor complex |
| 07/19/2000 | EP0821551A4 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 07/19/2000 | EP0760819B1 Tricyclic dicarbonyl derivatives |
| 07/19/2000 | EP0752989B1 Thiazolylpyrazolinones and their use for protecting technical materials |
| 07/19/2000 | EP0735877B1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| 07/19/2000 | EP0722320B1 Use of nitric oxide-releasing compounds as medicaments for hypoxic cell radiation sensitization |
| 07/19/2000 | EP0706373B1 Liposome encapsulated taxol and a method of using the same |
| 07/19/2000 | EP0674626B1 Selective aromatase inhibiting compounds |